论文部分内容阅读
目的:探索采用高效抗反转录病毒联合中成药唐草片治疗艾滋病(AIDS)的临床效果。方法:选取阳江市公共卫生医院2014年6月至2016年12月收治的22例感染者作为本次研究对象,将患者按照随机对照原则分为观察组和对照组,其中对照组患者采用高效抗反转录病毒治疗,观察组患者在对照组患者基础上加用中成药唐草片进行治疗。对两组患者治疗后症状变化以及实验室检查结果等进行对比。结果:观察组共有10例患者达到稳定以上标准,治疗总有效率为90.01%,对照组中共9例患者达到稳定以上标准,治疗总有效率为81.81%,观察组治疗总有效率明显高于对照组,差异具有统计学意义(P<0.05)。两组患者治疗前CD4 T细胞水平比较,差异无统计学意义(P>0.05);两组患者治疗后与治疗前相比,CD4 T细胞水平均出现增高,差异具有统计学意义(P<0.05),两组间治疗3个月后CD4 T细胞计数及差值比较,差异均无统计学意义(P>0.05)。结论:采用高效抗反转录病毒联合中成药唐草片治疗AIDS感染效果良好。
Objective: To explore the clinical effect of using highly effective antiretroviral combined with Chinese herbal medicine Tangcao Tablet in the treatment of AIDS. Methods: Twenty-two HIV-infected patients admitted from June 2014 to December 2016 in Yangjiang Public Health Hospital were selected as the study subjects. The patients were divided into observation group and control group according to the principle of randomization. Among them, Retrovirus treatment, observation group patients in the control group based on the use of proprietary Chinese medicine Tangcao tablets for treatment. The two groups of patients after treatment symptoms and laboratory test results were compared. Results: A total of 10 patients in the observation group reached a stable and above standard, the total effective rate was 90.01%. In the control group, 9 patients reached the stable standard, the total effective rate was 81.81%. The total effective rate in the observation group was significantly higher than that in the control group Group, the difference was statistically significant (P <0.05). There was no significant difference in the level of CD4 T cells between the two groups before treatment (P> 0.05). The levels of CD4 T cells in both groups were significantly higher than those before treatment (P <0.05) ), CD4 T cell count and difference between the two groups after treatment for 3 months, the difference was not statistically significant (P> 0.05). Conclusion: Highly effective antiretroviral combined with proprietary Chinese medicine Tangcao Tablet is effective in treating AIDS infection.